Float Short %

7.28

Margin Of Safety %

-9

Put/Call OI Ratio

0.23

EPS Next Q Diff

-0.19

EPS Last/This Y

1.33

EPS This/Next Y

-0.11

Price

35.63

Target Price

49.18

Analyst Recom

1.62

Performance Q

-8.08

Upside

-86.1%

Beta

1.92

Ticker: VCYT

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-23	VCYT	42.28	0.22	0.07	2249
2026-01-26	VCYT	40.56	0.22	0.07	2249
2026-01-27	VCYT	39.81	0.22	0.60	2265
2026-01-28	VCYT	38.47	0.22	0.64	2290
2026-01-29	VCYT	38.74	0.22	0.17	2302
2026-01-30	VCYT	38.07	0.23	0.00	2303
2026-02-02	VCYT	38.16	0.20	0.00	2565
2026-02-03	VCYT	37.72	0.20	0.50	2590
2026-02-04	VCYT	36.09	0.20	0.00	2606
2026-02-05	VCYT	34.86	0.20	0.10	2604
2026-02-06	VCYT	36.17	0.19	10.00	2669
2026-02-09	VCYT	36.74	0.18	39.83	2655
2026-02-10	VCYT	37.02	0.26	28.29	2837
2026-02-11	VCYT	35.98	0.25	0.04	2806
2026-02-12	VCYT	35.15	0.25	0.00	2819
2026-02-13	VCYT	35.8	0.23	0.00	2967
2026-02-17	VCYT	36.04	0.23	0.00	2974
2026-02-18	VCYT	36.61	0.23	0.00	2981
2026-02-19	VCYT	36.26	0.23	0.00	2987
2026-02-20	VCYT	35.63	0.23	0.00	2972
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-23	VCYT	42.27	8.7	66.2	1.65
2026-01-26	VCYT	40.57	11.2	65.6	1.65
2026-01-27	VCYT	39.78	11.2	68.0	1.65
2026-01-28	VCYT	38.45	13.4	69.2	1.65
2026-01-29	VCYT	38.72	13.4	73.9	1.65
2026-01-30	VCYT	38.01	13.4	70.9	1.65
2026-02-02	VCYT	38.15	13.4	73.4	1.65
2026-02-03	VCYT	37.71	13.4	71.8	1.65
2026-02-04	VCYT	36.11	13.4	68.1	1.65
2026-02-05	VCYT	34.89	13.4	69.2	1.65
2026-02-06	VCYT	36.17	13.4	77.6	1.65
2026-02-09	VCYT	36.77	13.4	75.0	1.65
2026-02-10	VCYT	37.05	13.4	74.2	1.65
2026-02-11	VCYT	35.97	13.4	69.8	1.65
2026-02-12	VCYT	35.17	13.4	70.4	1.65
2026-02-13	VCYT	35.77	13.4	75.2	1.65
2026-02-17	VCYT	36.07	13.4	74.0	1.65
2026-02-18	VCYT	36.62	13.4	75.0	1.65
2026-02-19	VCYT	36.24	13.4	-	1.65
2026-02-20	VCYT	35.63	13.4	-	1.65
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-23	VCYT	-10.01	4.67	6.45
2026-01-26	VCYT	-10.01	4.39	6.45
2026-01-27	VCYT	-10.01	4.39	6.45
2026-01-28	VCYT	-10.01	4.39	6.69
2026-01-29	VCYT	-9.97	4.39	6.69
2026-01-30	VCYT	-9.97	4.39	6.69
2026-02-02	VCYT	-9.97	4.15	6.69
2026-02-03	VCYT	-10.01	4.15	6.69
2026-02-04	VCYT	-10.01	4.15	6.69
2026-02-05	VCYT	-10.01	4.15	6.69
2026-02-06	VCYT	-10.01	4.15	6.69
2026-02-09	VCYT	-10.01	0.43	6.69
2026-02-10	VCYT	-10.01	0.43	6.69
2026-02-11	VCYT	-10.01	0.43	7.28
2026-02-12	VCYT	-10.01	0.43	7.28
2026-02-13	VCYT	-10.01	0.43	7.28
2026-02-17	VCYT	-10.01	6.13	7.28
2026-02-18	VCYT	-10.01	6.13	7.28
2026-02-19	VCYT	-10.01	6.13	7.28
2026-02-20	VCYT	-10.01	6.13	7.28
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.51

Avg. EPS Est. Current Quarter

0.39

Avg. EPS Est. Next Quarter

0.32

Insider Transactions

-10.01

Institutional Transactions

6.13

Beta

1.92

Average Sales Estimate Current Quarter

131

Average Sales Estimate Next Quarter

130

Fair Value

32.46

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

50.6

Max Drawdown 5-Year %

-79

Target Price

49.18

P/E

93.84

Forward P/E

22.77

PEG

0.3

P/S

5.69

P/B

2.24

P/Free Cash Flow

28.68

EPS

0.38

Average EPS Est. Cur. Y

1.65

EPS Next Y. (Est.)

1.53

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.12

Relative Volume

1.36

Return on Equity vs Sector %

-26.6

Return on Equity vs Industry %

-8.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.22

EBIT Estimation

Veracyte, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 824

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

stock quote shares VCYT – Veracyte, Inc. Stock Price stock today

news today VCYT – Veracyte, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VCYT – Veracyte, Inc. yahoo finance google finance

stock history VCYT – Veracyte, Inc. invest stock market

stock prices VCYT premarket after hours

ticker VCYT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VCYT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y